Publications by authors named "Kenro Tanoue"

Claim this Profile
M
Metastatic urachal carcinoma treated with trifluridine/tipiracil and bevacizumab: a case report.
Takafumi Kitazono, Taichi Isobe, Satoshi Nishiyori, Wataru Kusano, Kenro Tanoue

Int Cancer Conf J· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I/II trial evaluating the safety of increased-dose S- 1 with oxaliplatin and nivolumab in HER2-negative advanced gastric cancer.
Keisuke Baba, Nobumi Suzuki, Chiyo K Imamura, Eisuke Booka, Masashi Takeuchi, Kenro Tanoue

BMC Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatial dynamics of CD39CD8 exhausted T cell reveal tertiary lymphoid structures-mediated response to PD-1 blockade in esophageal cancer.
Kenro Tanoue, Hirofumi Ohmura, Koki Uehara, Mamoru Ito, Kyoko Yamaguchi

Nat Commun· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Genomic Alterations on Efficacy of Trastuzumab Deruxtecan Against Human Epidermal Growth Factor Receptor-2-Positive Advanced Gastric Cancer.
Kyoko Yamaguchi, Mamoru Ito, Taichi Isobe, Sakuya Koreishi, Ryosuke Taguchi, Kenro Tanoue

JCO Precis Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preferential B cell differentiation by combined immune checkpoint blockade for renal cell carcinoma is associated with clinical response and autoimmune reactions.
Koki Uehara, Kenro Tanoue, Kyoko Yamaguchi, Hirofumi Ohmura, Mamoru Ito

Cancer Immunol Immunother· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presence of spontaneous epithelial-mesenchymal plasticity in esophageal cancer.
Kenji Tsuchihashi, Yuki Hirata, Juntaro Yamasaki, Kentaro Suina, Kenro Tanoue

Biochem Biophys Rep· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macrophages are primed to transdifferentiate into fibroblasts in malignant ascites and pleural effusions.
Mamoru Ito, Michitaka Nakano, Hiroshi Ariyama, Kyoko Yamaguchi, Risa Tanaka, Kenro Tanoue

Cancer Lett· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prominent PD-L1-positive M2 macrophage infiltration in gastric cancer with hyper-progression after anti-PD-1 therapy: A case report.
Kyoko Yamaguchi, Kenji Tsuchihashi, Kunihiro Tsuji, Yosuke Kito, Kenro Tanoue

Medicine (Baltimore)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive impact of C-reactive protein to albumin ratio for recurrent or metastatic head and neck squamous cell carcinoma receiving nivolumab.
Kenro Tanoue, Shingo Tamura, Hitoshi Kusaba, Yudai Shinohara, Mamoru Ito

Sci Rep· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eribulin as a first-line treatment for soft tissue sarcoma patients with contraindications for doxorubicin.
Kenji Tsuchihashi, Hitoshi Kusaba, Tomoyasu Yoshihiro, Toshifumi Fujiwara, Nokitaka Setsu, Kenro Tanoue

Sci Rep· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis